Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Go back to Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 87.90 -1.81 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.71 | 52 Week High | $96.38 | |||
| Open | $88.78 | 52 Week Low | $47.92 | |||
| Day High | $89.00 | P/E | N/A | |||
| Day Low | $87.65 | EPS | $-0.42 | |||
| Volume | 2,361,539 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1149.36 -10.24 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1159.60 | 52 Week High | $88.16 | |||
| Open | $1150.61 | 52 Week Low | $67.88 | |||
| Day High | $1158.44 | P/E | 266.06 | |||
| Day Low | $1138.31 | EPS | $4.32 | |||
| Volume | 2,219,855 | |||||

